MANZO, ANTONIO
 Distribuzione geografica
Continente #
NA - Nord America 2.553
AS - Asia 2.077
EU - Europa 1.619
SA - Sud America 322
AF - Africa 78
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 6.651
Nazione #
US - Stati Uniti d'America 2.482
CN - Cina 934
SG - Singapore 471
IE - Irlanda 348
HK - Hong Kong 249
BR - Brasile 242
VN - Vietnam 228
RU - Federazione Russa 206
DE - Germania 196
IT - Italia 168
FI - Finlandia 164
UA - Ucraina 154
SE - Svezia 105
FR - Francia 99
GB - Regno Unito 78
ZA - Sudafrica 45
CA - Canada 44
IN - India 36
BD - Bangladesh 29
AR - Argentina 23
BE - Belgio 18
EC - Ecuador 17
ES - Italia 17
JP - Giappone 17
MX - Messico 16
PK - Pakistan 16
IQ - Iraq 14
CZ - Repubblica Ceca 13
NL - Olanda 13
TR - Turchia 13
PL - Polonia 12
CO - Colombia 11
ID - Indonesia 10
SA - Arabia Saudita 9
AT - Austria 8
CL - Cile 8
MA - Marocco 8
VE - Venezuela 8
PE - Perù 6
TN - Tunisia 6
MY - Malesia 5
PH - Filippine 5
UZ - Uzbekistan 5
KZ - Kazakistan 4
LT - Lituania 4
CR - Costa Rica 3
EG - Egitto 3
IL - Israele 3
JO - Giordania 3
KE - Kenya 3
LB - Libano 3
NP - Nepal 3
PY - Paraguay 3
BG - Bulgaria 2
BO - Bolivia 2
ET - Etiopia 2
JM - Giamaica 2
KW - Kuwait 2
PS - Palestinian Territory 2
QA - Qatar 2
RO - Romania 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AM - Armenia 1
AO - Angola 1
AU - Australia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
CG - Congo 1
CI - Costa d'Avorio 1
CU - Cuba 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
GN - Guinea 1
GR - Grecia 1
HN - Honduras 1
IR - Iran 1
KG - Kirghizistan 1
KR - Corea 1
LK - Sri Lanka 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
MK - Macedonia 1
MM - Myanmar 1
MU - Mauritius 1
NG - Nigeria 1
NO - Norvegia 1
OM - Oman 1
PA - Panama 1
PT - Portogallo 1
Totale 6.646
Città #
Dublin 347
Chandler 323
Singapore 248
Hong Kong 240
San Jose 228
Ashburn 218
Jacksonville 218
Dallas 200
Beijing 172
Nanjing 169
Boardman 103
Ho Chi Minh City 84
Nanchang 77
New York 77
Lauterbourg 70
Princeton 69
Lawrence 66
Wilmington 65
Changsha 62
Munich 60
Ann Arbor 57
Helsinki 57
Hebei 56
Shenyang 56
Los Angeles 55
Hanoi 52
Jiaxing 41
Medford 40
Johannesburg 39
Pavia 39
Shanghai 38
Milan 32
Buffalo 30
Moscow 30
Redondo Beach 30
Tianjin 26
São Paulo 22
Hangzhou 21
Piscataway 21
Da Nang 20
Turku 20
Montreal 19
Brussels 18
Toronto 16
Tokyo 14
Seattle 13
Frankfurt am Main 12
The Dalles 12
Woodbridge 12
Brooklyn 11
Rio de Janeiro 11
Santa Clara 11
Houston 10
Nuremberg 10
Warsaw 10
Denver 9
London 9
Washington 9
Zhengzhou 9
Baghdad 8
Brno 8
Norwalk 8
Orem 8
Stockholm 8
Amsterdam 7
Boston 7
Chennai 7
Council Bluffs 7
Fairfield 7
Mexico City 7
Quito 7
Atlanta 6
Haiphong 6
Medellín 6
Rome 6
Turin 6
Brasília 5
Guangzhou 5
Guarulhos 5
Guayaquil 5
Kunming 5
Manchester 5
Phoenix 5
Poplar 5
Porto Alegre 5
Ribeirão Preto 5
San Francisco 5
Santiago 5
Secaucus 5
Tappahannock 5
Auburn Hills 4
Belo Horizonte 4
Caxias do Sul 4
Chongqing 4
Columbus 4
Dearborn 4
Delhi 4
Elk Grove Village 4
Islamabad 4
Lahore 4
Totale 4.322
Nome #
Assessment of synovitis to predict bone erosions in rheumatoid arthritis 149
B cells in rheumatoid arthritis: from pathogenic players to disease biomarkers 138
Methotrexate and glucocorticoids, but not anticytokine therapy, impair the immunogenicity of a single dose of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic inflammatory arthritis 134
Anti-citrullinated protein antibodies and high levels of rheumatoid factor are associated with systemic bone loss in patients with early untreated rheumatoid arthritis 123
Association of CXCL13 and CCL21 expression with the progressive organization of lymphoid-like structures in Sjögren's syndrome 119
Synovial tissue research: a state-of-the-art review 118
Ectopic lymphoid structures support ongoing production of class-switched autoantibodies in rheumatoid synovium 117
Reactogenicity, safety and disease flares following BNT162b2 mRNA COVID-19 vaccine in patients with chronic immune-inflammatory arthritis treated with biological and targeted synthetic disease-modifying anti-rheumatic drugs 117
Chemochine linfoidi nella sinovite reumatoide 116
T o B nell’Artrite Reumatoide 115
CCL21 expression pattern of human secondary lymphoid organ stroma is conserved in inflammatory lesions with lymphoid neogenesis 114
Clinical, Imaging, and Pathological Suppression of Synovitis in Rheumatoid Arthritis: Is the Disease Curable? 111
Chemokines in arthritis: key molecules in pathogenesis and potential therapeutic targets 110
B cell autoimmunity and bone damage in rheumatoid arthritis 110
Ultrasonographic and MRI characterisation of the palindromic phase of rheumatoid arthritis 109
Efficacy and safety of rituximab treatment in early primary Sjögren's syndrome: a prospective, multi-center, follow-up study 108
A Multicenter Retrospective Analysis Evaluating Performance of Synovial Biopsy Techniques in Patients With Inflammatory Arthritis: Arthroscopic Versus Ultrasound-Guided Versus Blind Needle Biopsy 108
Challenges in the diagnosis of early rheumatoid arthritis in times of COVID-19 107
Correspondence on 'EULAR December 2020 viewpoints on SARS-CoV-2 vaccination in patients with RMDs' 106
Current concepts and new developments in the treatment of psoriatic arthritis 106
B cell synovitis and clinical phenotypes in rheumatoid arthritis: relationship to disease stages and drug exposure 103
Systematic microanatomical analysis of CXCL13 and CCL21 in situ production and progressive lymphoid organization in rheumatoid synovitis 102
Subclinical remodelling of draining lymph node structure in early and established rheumatoid arthritis assessed by power Doppler ultrasonography 101
Role of chemokines and chemokine receptors in regulating specific leukocyte trafficking in the immune/inflammatory response 101
Multilevel examination of minor salivary gland biopsy for Sjogren’s syndrome significantly improves diagnostic performance of AECG classification criteria 100
Role of chemokines in the pathogenesis of chronic synovitis during rheumatoid arthritis 98
Established rheumatoid arthritis. The pathogenic aspects. 93
Impact of Anti-Citrullinated Protein Antibodies on Progressive Systemic Bone Mineral Density Loss in Patients With Early Rheumatoid Arthritis After Two Years of Treat-to-Target 92
The circulating interferon-inducible protein IFI16 correlates with clinical and serological features in rheumatoid arthritis 90
Inflammatory correlates of the Patient Global Assessment of Disease Activity vary in relation to disease duration and autoantibody status in patients with rheumatoid arthritis 89
Role of cell migration in the pathogenesis of rheumatoid arthritis: in vivo studies in SCID mice transplanted with human synovial membrane 89
No evidence of short-term impact of repeated BNT162b2 vaccination on rheumatoid arthritis homeostasis in drug-free remission 88
Meccanismi di danno articolare in corso di artrite reumatoide 88
Nuovi aspetti patogenetici dell’artrite reumatoide 88
A “Window of Therapeutic Opportunity” for Anti-Cytokine Therapy in Patients With Coronavirus Disease 2019 88
Involvement of subchondral bone marrow in rheumatoid arthritis: lymphoid neogenesis and in situ relationship to subchondral bone marrow osteoclast recruitment 87
Counter-regulation of regulatory T cells by autoreactive CD8+ T cells in rheumatoid arthritis. 87
Potential involvement of IL-9 and Th9 cells in the pathogenesis of rheumatoid arthritis 86
Insights Into the Concept of Rheumatoid Arthritis Flare 86
Limiting factors to Boolean remission differ between autoantibody-positive and -negative patients in early rheumatoid arthritis 84
The draining lymph node in rheumatoid arthritis: current concepts and research perspectives 83
IL-6 amplifies TLR mediated cytokine and chemokine production: implications for the pathogenesis of rheumatic inflammatory diseases 82
Synovial tissue heterogeneity and peripheral blood biomarkers 81
Neuroprotective effects of the Sigma-1 receptor (S1R) agonist PRE-084,in a mouse model of motor neuron disease not linked to SOD1 mutation 81
Use of ultrasound-guided small joint biopsy to evaluate the histopathologic response to rheumatoid arthritis therapy: recommendations for application to clinical trials 79
High serum levels of CXCL13 predict lower response to csDMARDs in both ACPA-positive and ACPA-negative early rheumatoid arthritis 77
Serum levels of CXCL13 are associated with ultrasonographic synovitis and predict power Doppler persistence in early rheumatoid arthritis treated with non-biological disease-modifying anti-rheumatic drugs 77
Synovial and serum B-cell signature of autoantibody-negative rheumatoid arthritis versus autoantibody-positive rheumatoid arthritis and psoriatic arthritis 76
Secondary and ectopic lymphoid tissue responses in rheumatoid arthritis: from inflammation to autoimmunity and tissue damage/remodeling 76
La membrana sinoviale 76
Prediction of long-term drug-free outcomes in ACPA-positive and ACPA-negative rheumatoid arthritis by combined clinical and ultrasound assessment of residual disease: a 5-year prospective study 75
Immunohistological assessment of the synovial tissue in small joints in rheumatoid arthritis: validation of a minimally invasive ultrasound-guided synovial biopsy procedure 75
Power Doppler ultrasonographic assessment of the joint-draining lymph node complex in rheumatoid arthritis: a prospective, proof-of-concept study on treatment with tumor necrosis factor inhibitors. 74
Lymphoid tissue reactions in rheumatoid arthritis 73
Targeting of viral interleukin-10 with an antibody fragment specific to damaged arthritic cartilage improves its therapeutic potency 73
Clinical Applications of Synovial Biopsy. 71
Progressive increase in time to referral and persistently severe clinical presentation over the years in autoantibody-negative patients with rheumatoid arthritis in the setting of an early arthritis clinic 71
High expression levels of the B cell chemoattractant CXCL13 in rheumatoid synovium are a marker of severe disease 68
Timely escalation to second-line therapies after failure of methotrexate in patients with early rheumatoid arthritis does not reduce the risk of becoming difficult-to-treat 67
Role of lymphoid chemokines in the development of functional ectopic lymphoid structures in rheumatic autoimmune diseases 67
Human single-chain variable fragment that specifically targets arthritic cartilage 66
La linfoneogenesi 66
Stromal cell-derived factor 1 (CXCL12) induces monocyte migration into human synovium transplanted onto SCID Mice 64
The access route through the anatomical snuffbox in ultrasound-guided synovial biopsy of the wrist allows for a safe and effective collection of tissue samples in inflammatory arthritis 63
Evaluation of Minimally Invasive, Ultrasound-guided Synovial Biopsy Techniques by the OMERACT Filter-Determining Validation Requirements 63
Tender joints in early autoantibody-negative rheumatoid arthritis: Should they be included in the scoring of joint involvement of the 2010 ACR/EULAR classification criteria? 61
Seronegative rheumatoid arthritis: one year in review 2023 61
The synovial membrane as a prognostic tool in rheumatoid arthritis 60
The Clinical Value of Autoantibodies in Rheumatoid Arthritis. 60
Stromal cell-derived factor 1 (CXCL12) induces human cell migration into human lymph nodes transplanted into SCID mice 58
Correction to: Standardisation of synovial biopsy analyses in rheumatic diseases: A consensus of the eular synovitis and omeract synovial tissue biopsy groups (Arthritis Research and Therapy (2018) 20 (265) DOI: 10.1186/s13075-018-1762-1) 57
Autoantibodies against chemokines post-SARS-CoV-2 infection correlate with disease course 57
Mature antigen-experienced T helper cells synthesize and secrete the B cell chemoattractant CXCL13 in the inflammatory environment of the rheumatoid joint 57
Standardisation of synovial biopsy analyses in rheumatic diseases: a consensus of the EULAR Synovitis and OMERACT Synovial Tissue Biopsy Groups. 52
Histopathology of the synovial tissue: Perspectives for biomarker development in chronic inflammatory arthritides. 51
Inflammatory lesions in the bone marrow of rheumatoid arthritis patients: a morphological perspective 51
The Genetic, Environmental, and Immunopathological Complexity of Autoantibody-Negative Rheumatoid Arthritis 47
ProNGF-p75NTR axis plays a proinflammatory role in inflamed joints: a novel pathogenic mechanism in chronic arthritis 45
Power Doppler ultrasonographic assessment of the joint-draining lymph node complex in rheumatoid arthritis: a prospective, proof-of-concept study on treatment with tumor necrosis factor inhibitors 44
Redox-Mediated Mechanisms Fuel Monocyte Responses to CXCL12/HMGB1 in Active Rheumatoid Arthritis. 43
Targeting the IL-6-Yap-Snail signalling axis in synovial fibroblasts ameliorates inflammatory arthritis 42
EULAR points to consider for minimal reporting requirements in synovial tissue research in rheumatology 35
ERRATUM to: Synovial tissue research: a state-of-the-art review (Nature Reviews Rheumatology 13, 463–475 (2017)) 32
Totale 6.912
Categoria #
all - tutte 29.250
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.250


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021112 0 0 0 0 0 0 0 0 0 52 45 15
2021/2022280 5 2 13 12 3 19 4 28 10 9 38 137
2022/20231.018 107 75 6 72 94 93 2 57 402 10 34 66
2023/2024478 39 110 17 33 39 140 13 28 4 8 28 19
2024/20251.133 20 86 16 15 10 54 77 61 289 57 155 293
2025/20262.450 218 217 333 272 284 106 511 159 200 150 0 0
Totale 6.912